Global Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Drug Type (Quinine, Chloroquine, Proguanil, Amodiaquine, Mefloquine, Hydroxychloroquine, Pyrimethamine, Others), By Drug Class (Aryl Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds, Antimicrobials), By Route of Administration (Oral, Powder Inhalation, Intrav

According to the “World Malaria Report 2021” by World Health Organization (WHO), in 2020, there were approximately 228 million cases and about 6,02,000 malaria-related deaths

According to World Health Organization (WHO), about half of the world's population is at risk of malaria.

Global antimalarial drugs market can be segmented based on

Based on route of administration, the global

Major companies operating in global antimalarial drugs market include Cipla Ltd, GlaxoSmithKline Plc, Ipca Laboratories Ltd., Merck & Co., Inc, Novartis AG, Zydus Cadila, Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories), Strides Pharma Science Limited, Glenmark Pharmaceuticals Ltd., and Lincoln Pharmaceuticals Ltd. The market players are adopting growth strategies like new product launches, mergers & partnerships to increase their global market share.

Download Free Sample Report

Objective of the Study

• To analyze and forecast the market size of global antimalarial drugs market.
• To forecast global antimalarial drugs market based on drug type, drug class, route of administration, malaria type, application, distribution channel, company and regional distribution.
• To identify drivers and challenges for global antimalarial drugs market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global antimalarial drugs market.
• To identify and analyse the profile of leading players operating in the global antimalarial drugs market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of antimalarial drugs companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated global antimalarial drugs market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience

• Antimalarial drugs companies/partners, investors, and other stakeholders
• Hospital pharmacy/ retail pharmacy
• Government bodies such as regulating authorities and policy makers
• Organizations, industry associations, forums and alliances related to antimalarial drugs
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as antimalarial drugs vendors, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.